ClinicalTrials.gg
RecruitingNCT07945639ET+Updated Nov 18, 2026

Exploring Trauma Plus (ET+)

An interventional study of Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations (Covington & Rodriguez, 2016, rev. 2021) in Trauma and Stress-related Disorders, Anxiety and Depression Anxiety Disorder, sponsored by Envisioning Justice Solutions, Inc. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Envisioning Justice Solutions, Inc · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Apr 2026, registered Nov 2026).
  • Started Apr 2026; still recruiting 7 months later.
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 32 studies in Trauma and Stressor Related Disorders with a site in United States — 21 open to participants now, 21 under way, 1 of them phase 3. Trauma and Stressor Related Disorders · United States.

Planned enrollment
3rd of 31
250 · median 50
Started
2026
with 6 others
No phase
26 of 32
20 open now
Primary completion
2028-06
later than 14 of 20 live
Registered
32nd of 32
by date
Lead sponsor
1 of 32
Envisioning Justice Solutions, Inc

Among the 32 studies in Trauma and Stressor Related Disorders with a site in United States, this one is the 3rd largest by planned enrollment of the 31 interventional ones that give a count, is one of 7 that started in 2026, is one of 26 with no phase, reaches primary completion later than 14 of the 20 other live ones, and was the 32nd registered.

Trauma and Stressor Related Disorders

55 studies on the registry are indexed under Trauma and Stressor Related Disorders; 30 are open to participants now.

Browse Trauma and Stressor Related Disorders studies →

Open to participants now

21 of the 32 studies in Trauma and Stressor Related Disorders with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 24 Trauma and Stressor Related Disorders studies recruiting now, 9 (38%) set no upper age limit and 10 (42%) stop at 75 or younger; 4 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Trauma and Stressor Related Disorders with a site in United States, or all of them as a file.
02

Study summary

This randomized controlled trial evaluates Exploring Trauma Plus (ET+), a brief, manualized, trauma-specific intervention designed for justice-involved men and transgender and gender-diverse individuals. The six-session curriculum uses psychoeducation, cognitive-behavioral strategies, mindfulness, grounding techniques, and structured exercises to help participants understand trauma, manage trauma-related distress, and develop coping skills.

The study is beging conducted at a California correctional facility for men and compares participants randomly assigned to ET+ with participants assigned to a waitlist control condition. The program is delivered by trained peer facilitators in general institutional housing on a custody level III yard.

Researchers assess changes in trauma-related distress, behavioral health symptoms, anger, and aggression using validated self-report measures administered before and after the intervention period.

Read the detailed description

The primary objective of the randomized controlled trial is to assess the effectiveness of the Exploring Trauma Plus (ET+) curriculum at reducing co-occurring trauma, anger, and aggression among men and the transgender and gender-diverse (TGD) community. Using a randomized experimental design, this study aims to quantitatively measure change on specifically targeted outcome measures over time spent in the ET+ program among a group of males and TGD individuals who participate in the program (treatment group) versus a group of similar males and TGD individuals who did not participate in the program (control group). Refined inferential statistical analyses will be employed to analyze the data collected and explore an integrated model of trajectories of trauma and aggression among participants in prison.

ET+ is a 6-week 6-session trauma-informed program that utilizes Peer Facilitators. Peer facilitators are individuals serving long-term sentences who volunteered for these positions and were specially trained to facilitate the program for other institutional residents who participate in the program.

Institutional Review Board (IRB) approval was received on May 23, 2024. CDCR Research Oversight Committee approvals and Data Sharing Agreements were sought and also approved. Oversight will continue throughout the duration of the study.

Researchers will use a randomization design to test the effectiveness of the ET+ curriculum to reduce trauma-related difficulties (i.e., mental health symptoms, trauma, anger, hostility and aggression) and to increase Restorative Justice outcome measures (i.e., resilience, social connectedness, empathy, and accountability for the harm that has been produced).

Measured outcomes will include PTSD symptoms (Trauma Symptoms Checklist [TSC-40] and the Short Screening Scale for DSM-IV PTSD), depression (Patient Health Questionnaire - Depression Subscale), anxiety (Patient Health Questionnaire - Anxiety), aggression (Buss-Warren Aggression Questionnaire), mental health functioning (K6 Brief Mental Health Screen), instrumental and expressive anger (Revised Instrumental and Expressive Representation Scales), the Brief Resilient Coping Scale, and the Dickman Impulsivity Scale.

03

Conditions studied

  • Trauma and Stress-related Disorders
  • Anxiety
  • Depression Anxiety Disorder
  • Anger Problems
  • Aggression

Keywords

  • trauma-responsive
  • transgender
  • incarceration
  • adverse childhood experiences
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: All participants who expressed interest in participating in the study at the California men's prison and who were capable of providing written .

-

Exclusion Criteria: There were no study-defined exclusion criteria; operational exclusions or security restrictions were at the discretion of prison administration.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Exploring Trauma Plus Brief Intervention

    This revised evidence-based six-session trauma intervention is designed for people who have experienced abuse and trauma. The understanding of gender has shifted from the binary male-female model to a more inclusive and expansive model. This second edition of Exploring Trauma is now entitled Exploring Trauma+: A Brief Intervention for Men and Gender-Diverse People in order to reflect the changes in this new edition. The definition of gender responsiveness has been expanded to include the experiences of transgender and nonbinary people. This new material has inclusive pronouns, as well as examples of traumatic events and focus questions specific to this group. The materials focus on the three core things that both staff and clients need: an understanding of what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships).

    Behavioral: Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations (Covington & Rodriguez, 2016, rev. 2021)

  • No intervention
    Waitlist Control Group

    Participants assigned to the waitlist control condition, serving as the comparison group during the study. Participants are offered Exploring Trauma Plus (ET+) after their study participation.

Interventions

  • BehavioralExploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations (Covington & Rodriguez, 2016, rev. 2021)

    ET+ is an evidence-based 6-session brief intervention with a focus on trauma and PTSD, and techniques for Restorative Justice work with men (and those who identify as men). The rigorously evaluated manualized curriculum is designed for trauma treatment while emphasizing Restorative Justice principles and objectives, e.g., understanding victim impact, personal accountability, and restitution. The intervention is delivered to small groups of 10-12 men and co-led by two specially trained Peer Facilitators. Using a closed group model creates the experience of a prosocial support system based on a new value system and group agreements. This is strengthened by using Peer Facilitators as role models. The group process helps develop empathy and connectedness for other group members.

06

What researchers measure

Primary outcomes

  1. Modified Short Screening Scale for DSM-IV PTSD (7-item symptom index, following a trauma-exposure screen)

    The Modified Short Screening Scale for DSM-IV PTSD is a 7-item measure assessing the frequency of posttraumatic stress symptoms following exposure to a traumatic event. Items assess symptom frequency over the preceding four weeks, with responses ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

    Time frame: Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.

  2. Patient Health Questionnaire (PHQ) Anxiety Subscale

    The Patient Health Questionnaire (PHQ) Anxiety Subscale is a 7-item measure assessing the frequency of anxiety symptoms over the preceding four weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score range is 0-18, with higher scores indicating greater anxiety symptom frequency.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  3. PHQ-9 Depression Subscale

    The Patient Health Questionnaire-9 (PHQ-9) is a 9-item measure assessing the frequency of depressive symptoms over the preceding two weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  4. TSC-40 composite score.

    The Trauma Symptom Checklist-40 (TSC-40) is a 40-item measure assessing trauma-related symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). The composite score ranges from 0 to 120, with higher scores indicating greater trauma-related distress.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  5. TSC-40 Anxiety Subscale

    The Anxiety subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related anxiety symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater anxiety symptoms.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  6. TSC-40 Depression Subscale

    The Depression subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related depressive symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Secondary outcomes

  1. TSC-40 Outcome Measures 1. Dissociation Subscale

    The Dissociation subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 6 items assessing dissociative symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater dissociative symptoms.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  2. TSC-40 Outcome Measures 2. Sexual Abuse Trauma Index (SATI)

    The Sexual Abuse Trauma Index (SATI) of the TSC-40 consists of 7 items assessing symptoms associated with sexual abuse trauma over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  3. TSC-40 Outcome Measures 3. Sleep Disturbances Subscale

    The Sleep Disturbances subscale of the TSC-40 consists of 6 items assessing sleep-related difficulties over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater sleep disturbance.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  4. Buss-Warren Aggression Questionnaire (AQ)

    A measure of aggressive behavior and tendencies. ET+ uses only the Verbal Aggression and Physical Aggression subscales to assess verbal and physical expressions of aggression.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

  5. Brief Resilient Coping Scale

    A 4-item measure assessing the ability to cope with stress in an adaptive and resilient manner.

    Time frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

07

Study locations

1 of 1 sites recruiting
  • California State Prison, Corcoran
    Corcoran, California 93212, United States
    Recruiting
08

References and documents

Publications

  • Messina NP. An Experimental Study of the Effectiveness of a Trauma- Specific Intervention for Incarcerated Men. J Interpers Violence. 2023 Feb;38(3-4):3088-3112. doi: 10.1177/08862605221104526. Epub 2022 May 27. PubMed 35623631 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared because sharing is subject to applicable data-use restrictions and authorization from the California Department of Corrections and Rehabilitation (CDCR).

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Jun 2028, 26 months after the start.

Of 33 interventional studies with no phase under Trauma and Stressor Related Disorders, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 20. This study's planned 26 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 18, 2026
StartActual
Apr 1, 2026
Primary completionEst.
Jun 30, 2028
CompletionEst.
Jun 30, 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945639
Lead sponsor
Envisioning Justice Solutions, Inc
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
Apr 1, 2026
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

NENA Messina, PhD
Contact
Nena@envisioningjusticesolutions.com
3108018996
NENA P Messina
principal investigator · Envisioning Justice Solutions, Inc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion